Biotech Oblique Therapeutics announces that NaV 1.8 project is advancing to next stage October 22, 2024
Biotech Okomera Gets €1.5 Million Grant to Develop Microfluidics & AI Powered CRISPR Editing Platform for Target Validation October 21, 2024
Biotech NIANCE Unveils Groundbreaking White Paper on Beauty and Longevity: Addressing the 12 Hallmarks of Aging October 21, 2024
Biotech MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum October 19, 2024
Biotech Accord Healthcare receives positive CHMP opinion for IMULDOSA®, a ustekinumab biosimilar to Stelara® October 19, 2024
Biotech 111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow October 18, 2024
Biotech Evergreen Theragnostics opens CCK2-VIEW, a Phase II small cell lung cancer clinical trial, in the European Union October 18, 2024
Biotech LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing October 18, 2024